John L. Berk
Impact in
- Nephrology top 0.2%
- Parathyroid Disorders and Treatments
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
- Nephrology 36
- Parathyroid Disorders and Treatments 31
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 129
- Protein Kinase Regulation and GTPase Signaling 17
- Co-authors
- Frederick L. RubergVaishali SanchorawalaDavid C. SeldinMartha SkinnerLaura M. DemberRodney H. FalkMárcia Waddington‐CruzLawreen H. Connors
- Journals
- Amyloid (29 papers)Blood (10 papers)Neurology (10 papers)Circulation (6 papers)Journal of the Peripheral Nervous System (5 papers)
- Partner nations
- United StatesPortugalFrance
In The Last Decade
John L. Berk
151 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Nephrology 1.7k
- Genetics 1.1k
- Molecular Biology 6.1k
- Rheumatology 1.1k
- Oncology 1.4k
Countries citing papers authored by John L. Berk
This map shows the geographic impact of John L. Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Berk more than expected).
Fields of papers citing papers by John L. Berk
This network shows the impact of papers produced by John L. Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Berk. The network helps show where John L. Berk may publish in the future.
Co-authors
The 25 scholars most cited alongside John L. Berk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 19 | |
| 8 | 2021 | 1 | |
| 9 | Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis Hit paper breakdown → | 2019 | 316 |
| 10 | 2019 | 2 | |
| 11 | Abstract 13123: Diflunisal is Associated With Improved Mortality in Patients With Wild-Type ATTR Cardiac Amyloidosis: The BU Amyloidosis Center Experience | 2019 | 2 |
| 12 | Infusion related reactions in patients with hATTR amyloidosis treated with patisiran | 2018 | 2 |
| 13 | Neuropathy progression in patients with hATTR amyloidosis : Analysis of the APOLLO placebo arm | 2018 | 0 |
| 14 | 2018 | 1 | |
| 15 | EFFECT OF PATISIRAN ON NERVE FIBER DENSITY AND AMYLOID CONTENT IN SKIN : RESULTS FROM PHASE 2 OPEN LABEL EXTENSION (OLE) STUDY IN HATTR AMYLOIDOSIS | 2017 | 1 |
| 16 | 2017 | 10 | |
| 17 | 2015 | 22 | |
| 18 | Abstract 12603: Global T1 Mapping and Late Gadolinium Enhancement Cardiac MR in Myocardial Fibrosis Compared with Amyloid Cardiomyopathy | 2012 | 1 |
| 19 | 1983 | 4 | |
| 20 | 1973 | 29 |
About John L. Berk
John L. Berk is a scholar working on Nephrology, Molecular Biology, Genetics, Rheumatology and Cell Biology, having authored 155 papers that have together received 6.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (129 papers), Parathyroid Disorders and Treatments (31 papers), Peptidase Inhibition and Analysis (19 papers), Protein Kinase Regulation and GTPase Signaling (17 papers), Neuroendocrine Tumor Research Advances (17 papers), Eosinophilic Disorders and Syndromes (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Cellular transport and secretion (11 papers). The work is most often cited by research in Nephrology (1.7k citations), Genetics (1.1k citations), Molecular Biology (6.1k citations), Rheumatology (1.1k citations) and Oncology (1.4k citations). John L. Berk has collaborated with scholars based in United States, Portugal and France. Frequent co-authors include Frederick L. Ruberg, Vaishali Sanchorawala, David C. Seldin, Martha Skinner, Laura M. Dember, Rodney H. Falk, Márcia Waddington‐Cruz, Lawreen H. Connors, Teresa Coelho and Violaine Planté‐Bordeneuve. Their work appears in journals such as Amyloid, Blood, Neurology, Circulation and Journal of the Peripheral Nervous System.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.